CC

Claritev Corporation

CTEVยทNYSE

$27.75

-2.1%
HealthcareMedical - Healthcare Information Services

Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and network-based services that provide contracted discounts with healthcare providers, as well as outsourced network development and management services. It provides payment and revenue integrity services, such as identifying and removing improper and unnecessary charges paid during the claim, as well as services to identify and help restore and preserve underpaid premium dollars. In addition, the company offers data and decision science services including a suite of solutions that apply modern methods of data science to produce descriptive, predictive, and prescriptive analytics that drive optimized benefit plan design, support decision-making, improve clinical outcomes, and reduce the total cost of care; and business-to-business healthcare payments and other services. It serves national and regional insurance companies, Blue Cross and Blue Shield plans, provider-sponsored and independent health plans, TPAs, self-insured health plans, property and casualty insurers, bill review companies, and other companies involved in the claim adjudication process. The company was formerly known as MultiPlan Corporation and changed its name to Claritev Corporation in February 2025. Claritev Corporation was founded in 1980 and is headquartered in New York, New York.

At a Glance

Live Snapshot
Market Cap$473.08M
EPS-17.3000
P/E Ratio-1.60
Earnings Date08/05/2026
3Y-68.0%
5Y-69.0%
10Y-60.0%
3Y+16.0%
5Y-43.0%
10Y+90.0%
3Y-102.0%
5Y-104.0%
10Y-101.0%
C

Claritev Corporation Cash Conversion Engine

CTEV ยท NYSE
Net Income-284.28M
Depreciation & Amortization445.43M
Stock-Based Compensation27.82M
Change in Working Capital-28.87M
Others85.73M
Capital Expenditures-129.60M
Free Cash Flow-12.28M

Cash Flow Quality Analysis

FCF Conversion Rate

4.3%

Weak cash conversion. Significant portion of earnings not converting to cashโ€”review working capital trends and capital intensity.

CapEx Intensity

110.5%

Very high capital intensity consumes most operating cash flow. Limited flexibility for dividends or debt reduction.

FCF Growth Trend

-16.8%

Significant FCF decline raises concerns. Urgent review needed of operational performance and capital allocation.

Working Capital Impact

-$28.87M

Significant working capital drain. Growth may be consuming cash through inventory buildup or receivables extensionโ€”monitor closely.

Cash Flow Quality Insight

Deteriorating cash generation: Both declining FCF and weak conversion rate signal fundamental challenges. Investigate margin pressure, rising costs, or working capital issues.

Claritev Corporation Cash Flow Statement

CTEV โ€ข NYSE

Claritev Corporation Cash Flow StatementDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
OPERATING ACTIVITIES
-284.3M
-1.6B
-91.7M
-572.9M
102.1M
-520.6M
9.7M
36.2M
445.4M
436.4M
425.8M
415.7M
424.3M
403.7M
399.5M
386.3M
-128.5M
-198M
-114.1M
-114.4M
0.0
-45M
-111.4M
-112.5M
27.8M
26.6M
18M
16.7M
18M
406.1M
-14.9M
4.7M
85.7M
1.5B
-44.4M
571.9M
-93M
103.2M
-4.9M
15.1M
(0.0)
(80.1M)
(0.0)
(0.0)
(0.0)
(3.9M)
(114.6M)
(116.6M)
-28.9M
-13.7M
-21.9M
55.3M
-46.7M
30M
6.4M
-37.6M
117.3M
107.6M
171.7M
372.4M
404.7M
377.4M
284.3M
292.3M
INVESTING ACTIVITIES
-129.6M
-118.1M
-108.9M
-89.7M
-84.6M
-70.8M
-66.4M
-63.6M
(0.0)
(0.0)
-140.9M
(0.0)
-149.4M
-140M
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
-15M
(0.0)
(0.0)
(0.0)
(0.0)
16M
0.0
0.0
289K
0.0
0.0
0.0
0.0
-7.4M
0.0
0.0
0.0
5.6M
0.0
0.0
0.0
-121M
-118.1M
-249.8M
-104.4M
-228.4M
-210.8M
-66.4M
-63.6M
FINANCING ACTIVITIES
1.7M
-10.4M
-14.7M
-100M
-103.8M
-101.1M
0.0
0.0
4.7M
-28.1M
-165.8M
-13.3M
-10.9M
2.2B
-201.1M
-245.2M
(0.0)
-10.4M
-15.2M
-100M
-103.8M
-101.1M
(0.0)
(0.0)
-4.1M
-2.9M
-465K
-2.5M
0.0
-2.2B
0.0
0.0
2.4M
-41.3M
-181M
-115.7M
-114.7M
-61.6M
-201.1M
-245.2M
CASH FLOW SUMMARY
-1.3M
-51.8M
-259.1M
152.2M
61.6M
104.9M
16.8M
-16.4M
29.7M
81.5M
340.6M
188.4M
126.8M
21.8M
5M
21.4M
28.3M
29.7M
81.5M
340.6M
188.4M
126.8M
21.8M
5M
-12.3M
-10.5M
62.9M
282.6M
320.1M
306.6M
217.9M
228.7M

SEC Filings

CTEV - Filing history and reports

Filing TypeFiling DatePeriod EndingFiscal YearActions
8-K

8-K 2026

N/A

May 18, 2026
May 18, 2026
2026
10-Q

10-Q 2026 Q1

Q1

May 07, 2026
March 31, 2026
2026
8-K

8-K 2026

N/A

May 07, 2026
May 07, 2026
2026
8-K

8-K 2026

N/A

April 30, 2026
April 29, 2026
2026
DEF 14A

DEF 14A 2026

N/A

March 20, 2026
April 29, 2026
2026
8-K

8-K 2026

N/A

March 16, 2026
March 16, 2026
2026
10-K

10-K 2025 FY

FY

February 26, 2026
December 31, 2025
2025
8-K

8-K 2026

N/A

February 23, 2026
February 23, 2026
2026
8-K

8-K 2026

N/A

January 15, 2026
January 15, 2026
2026
8-K

8-K 2025

N/A

December 29, 2025
December 23, 2025
2025
Showing 1 to 10 of 138 filings